Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yangshenguo Guanxin Tablet vs Yixinshu Tablet in Stable Angina
CTR20131171Phase 3Active
- Sponsor
- Institute of Regenerative Medicine, Jilin University
- Start
- Apr 2015
- Countries
- 1
01
Overview
A Phase 3 trial of Yangshenguo Guanxin Tablet in coronary arteriosclerosis, stable angina, sponsored by Institute of Regenerative Medicine, Jilin University. Started Apr 2015; status: active.
02
Drugs
Yangshenguo Guanxin Tablet
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on CTR20131171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131171.